These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Novel 3'-Substituted-1',2',4'-Oxadiazole Derivatives of 18βH-Glycyrrhetinic Acid and Their Markov AV; Sen'kova AV; Popadyuk II; Salomatina OV; Logashenko EB; Komarova NI; Ilyina AA; Salakhutdinov NF; Zenkova MA Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429154 [TBL] [Abstract][Full Text] [Related]
3. In-Silico screening of Pleconaril and its novel substituted derivatives with Neuraminidase of H1N1 Influenza strain. Hussain Basha S; Prasad RN BMC Res Notes; 2012 Feb; 5():105. PubMed ID: 22340192 [TBL] [Abstract][Full Text] [Related]
4. N-benzyl 4,4-disubstituted piperidines as a potent class of influenza H1N1 virus inhibitors showing a novel mechanism of hemagglutinin fusion peptide interaction. de Castro S; Ginex T; Vanderlinden E; Laporte M; Stevaert A; Cumella J; Gago F; Camarasa MJ; Luque FJ; Naesens L; Velazquez S Eur J Med Chem; 2020 May; 194():112223. PubMed ID: 32220685 [TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of pinane oxime derivatives as novel anti-influenza agents. Dong J; Xiao M; Ma Q; Zhang G; Zhao W; Kong M; Zhang Y; Qiu L; Hu W Bioorg Chem; 2020 Sep; 102():104106. PubMed ID: 32739481 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of NH Wang K; Yang F; Wang L; Liu K; Sun L; Lin B; Hu Y; Wang B; Cheng M; Tian Y Eur J Med Chem; 2017 Dec; 141():648-656. PubMed ID: 29107426 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and anti-H5N1 virus activity of triazole- and oxadiazole-pyrimidine hybrids and their nucleoside analogs. Tolan HEM; El-Sayed WA; Tawfek N; Abdel-Megeid FME; Kutkat OM Nucleosides Nucleotides Nucleic Acids; 2020; 39(5):649-670. PubMed ID: 31599202 [TBL] [Abstract][Full Text] [Related]
11. Discovery of a new class of antiviral compounds: camphor imine derivatives. Sokolova AS; Yarovaya OI; Shernyukov AV; Gatilov YV; Razumova YV; Zarubaev VV; Tretiak TS; Pokrovsky AG; Kiselev OI; Salakhutdinov NF Eur J Med Chem; 2015 Nov; 105():263-73. PubMed ID: 26498572 [TBL] [Abstract][Full Text] [Related]
12. Tautomeric and non-tautomeric N-substituted 2-iminobenzimidazolines as new lead compounds for the design of anti-influenza drugs: An in vitro study. Zarubaev VV; Morkovnik AS; Divaeva LN; Karpinskaya LA; Borodkin GS Bioorg Med Chem; 2016 Nov; 24(22):5796-5803. PubMed ID: 27670100 [TBL] [Abstract][Full Text] [Related]
13. A Small-Molecule Compound Has Anti-influenza A Virus Activity by Acting as a ''PB2 Inhibitor". Liu T; Liu M; Chen F; Chen F; Tian Y; Huang Q; Liu S; Yang J Mol Pharm; 2018 Sep; 15(9):4110-4120. PubMed ID: 30102858 [TBL] [Abstract][Full Text] [Related]
14. New type of anti-influenza agents based on benzo[d][1,3]dithiol core. Khomenko TM; Zarubaev VV; Kireeva MV; Volobueva AS; Slita AV; Borisevich SS; Korchagina DV; Komarova NI; Volcho KP; Salakhutdinov NF Bioorg Med Chem Lett; 2020 Dec; 30(24):127653. PubMed ID: 33129992 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of novel L-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors. Wang H; Xu R; Shi Y; Si L; Jiao P; Fan Z; Han X; Wu X; Zhou X; Yu F; Zhang Y; Zhang L; Zhang L; Zhou D; Xiao S Eur J Med Chem; 2016 Mar; 110():376-88. PubMed ID: 26866456 [TBL] [Abstract][Full Text] [Related]
16. Neoechinulin B and its analogues as potential entry inhibitors of influenza viruses, targeting viral hemagglutinin. Chen X; Si L; Liu D; Proksch P; Zhang L; Zhou D; Lin W Eur J Med Chem; 2015 Mar; 93():182-95. PubMed ID: 25681711 [TBL] [Abstract][Full Text] [Related]
17. An oligothiophene compound neutralized influenza A viruses by interfering with hemagglutinin. Shen X; Zhu Z; Ding Y; Wu W; Yang J; Liu S Biochim Biophys Acta Biomembr; 2018 Mar; 1860(3):784-791. PubMed ID: 29229526 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and antiviral activity of substituted bisaryl amide compounds as novel influenza virus inhibitors. Hao LH; Li YP; He WY; Wang HQ; Shan GZ; Jiang JD; Li YH; Li ZR Eur J Med Chem; 2012 Sep; 55():117-24. PubMed ID: 22824205 [TBL] [Abstract][Full Text] [Related]
19. An N-terminal heptad repeat trimer-based peptide fusion inhibitor exhibits potent anti-H1N1 activity. Na H; Luo H; Wang J; Sun L; Gao X; Liang G; Ma Y; Meng Z Bioorg Med Chem; 2024 Sep; 111():117865. PubMed ID: 39098126 [TBL] [Abstract][Full Text] [Related]
20. Modular Biomimetic Strategy Enables Discovery and SAR Exploration of Oxime Macrocycles as Influenza A Virus (H1N1) Inhibitors. Xu D; Gong Y; Zhang L; Xiao F; Wang X; Qin J; Tan L; Yang T; Lin Z; Xu Z; Liu X; Xiao F; Zhang F; Tang F; Zuo J; Luo X; Huang W; Yang L; Yang W J Med Chem; 2024 May; 67(10):8201-8224. PubMed ID: 38736187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]